Passa al contenuto
Merck

Structural Elucidation of Viral Antagonism of Innate Immunity at the STAT1 Interface.

Cell reports (2019-11-14)
Md Alamgir Hossain, Florence Larrous, Stephen M Rawlinson, Jingyu Zhan, Ashish Sethi, Youssef Ibrahim, Maria Aloi, Kim G Lieu, Yee-Foong Mok, Michael D W Griffin, Naoto Ito, Toyoyuki Ose, Hervé Bourhy, Gregory W Moseley, Paul R Gooley
ABSTRACT

To evade immunity, many viruses express interferon antagonists that target STAT transcription factors as a major component of pathogenesis. Because of a lack of direct structural data, these interfaces are poorly understood. We report the structural analysis of full-length STAT1 binding to an interferon antagonist of a human pathogenic virus. The interface revealed by transferred cross-saturation NMR is complex, involving multiple regions in both the viral and cellular proteins. Molecular mapping analysis, combined with biophysical characterization and in vitro/in vivo functional assays, indicates that the interface is significant in disease caused by a pathogenic field-strain lyssavirus, with critical roles for contacts between the STAT1 coiled-coil/DNA-binding domains and specific regions within the viral protein. These data elucidate the potentially complex nature of IFN antagonist/STAT interactions, and the spatial relationship of protein interfaces that mediate immune evasion and replication, providing insight into how viruses can regulate these essential functions via single multifunctional proteins.

MATERIALI
N° Catalogo
Marchio
Descrizione del prodotto

Sigma-Aldrich
D-Luciferin, synthetic
Sigma-Aldrich
D-glucosio-13C6, ≥99 atom % 13C, ≥99% (CP)
Sigma-Aldrich
Anticorpo di capra anti-IgG di topo, (H+L), coniugato con HRP, 1 mg/mL, Chemicon®
Sigma-Aldrich
Pyrimidine, ≥98.0%
Sigma-Aldrich
Coelenterazine h, solid